{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:17:51Z","timestamp":1793197071763,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE_00000019"],"award-info":[{"award-number":["PE_00000019"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117278","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T21:41:45Z","timestamp":1722980505000},"page":"117278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway"],"prefix":"10.1016","volume":"178","author":[{"given":"Letizia","family":"Mattii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Moscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ghelardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2024.117278_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188949","article-title":"Ponatinib: An update on its drug targets, therapeutic potential and safety","volume":"1878","author":"Gao","year":"2023","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117278_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.792751","article-title":"Multi-target drugs for blood cancer in the elderly: implications of damage and repair in the cardiovascular toxicity","volume":"12","author":"Madonna","year":"2021","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2024.117278_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/jcpt.12383","article-title":"Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report","volume":"41","author":"Tournaire","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2024.117278_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","article-title":"Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"11","author":"Caldemeyer","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.biopha.2024.117278_bib5","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2352-3026(15)00127-1","article-title":"Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study","volume":"2","author":"Jain","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.biopha.2024.117278_bib6","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1200\/JCO.2015.62.4718","article-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","volume":"33","author":"Moslehi","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117278_bib7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/jcmm.17008","article-title":"Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model","volume":"26","author":"Madonna","year":"2022","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2024.117278_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106949","article-title":"Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: a potential rescue strategy","volume":"142","author":"Madonna","year":"2022","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2024.117278_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gene.2017.09.036","article-title":"Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia","volume":"637","author":"Kayabasi","year":"2017","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2024.117278_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jat.3551","article-title":"Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines","volume":"38","author":"Mingard","year":"2018","journal-title":"J. Appl. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117278_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/toxsci\/kfn157","article-title":"Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells","volume":"106","author":"Will","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2024.117278_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkel\u00e4","year":"2006","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.117278_bib13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.117278_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.120.051824","article-title":"Effect of empagliflozin on cardiovascular and renal outcomes in patients with heart failure by baseline diabetes status: results from the EMPEROR-reduced trial","volume":"143","author":"Anker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117278_bib15","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117278_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jchf.2021.11.006","article-title":"Baseline characteristics of patients with HF with mildly reduced and preserved ejection fraction","volume":"10","author":"Solomon","year":"2022","journal-title":"Deliv. Trial JACC Heart Fail"},{"key":"10.1016\/j.biopha.2024.117278_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.117278_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2024.117278_bib19","unstructured":"\u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05271162\u3009."},{"key":"10.1016\/j.biopha.2024.117278_bib20","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1111\/jcmm.15699","article-title":"Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes","volume":"24","author":"Madonna","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2024.117278_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","article-title":"Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy","volume":"119","author":"Madonna","year":"2023","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2024.117278_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ejhf.1732","article-title":"Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors","volume":"22","author":"Packer","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2024.117278_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Arag\u00f3n-Herrera","year":"2019","journal-title":"Biochem. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2024.117278_bib24","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.3390\/ijms22115815","article-title":"Connexin 43 and connexin 26 involvement in the ponatinib-induced cardiomyopathy: sex-related differences in a murine model","volume":"22","author":"Madonna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2024.117278_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12860-016-0093-9","article-title":"Connexins: substrates and regulators of autophagy","volume":"17","author":"Iyyathurai","year":"2016","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.biopha.2024.117278_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109331","article-title":"Lead-induced cardiomyocytes apoptosis by inhibiting gap junction intercellular communication via autophagy activation","volume":"337","author":"Li","year":"2021","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2024.117278_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105263","article-title":"Diversity in connexin biology","volume":"299","author":"Lucaciu","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117278_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ncb2934","article-title":"Connexins modulate autophagosome biogenesis","volume":"16","author":"Bejarano","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2024.117278_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/pr.115.012062","article-title":"Connexins in cardiovascular and neurovascular health and disease: pharmacological implications","volume":"69","author":"Leybaert","year":"2017","journal-title":"Pharm. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.117278_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbamcr.2014.11.015","article-title":"H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation","volume":"1853","author":"Kuznetsov","year":"2015","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2024.117278_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129303","article-title":"Gene expression profiling of H9c2 myoblast differentiation towards a cardiac-like phenotype","volume":"10","author":"Branco","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.117278_bib32","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1074\/jbc.M411859200","article-title":"Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts","volume":"280","author":"Madonna","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117278_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32405-2","article-title":"Connexin 26 Expression in Mammalian Cardiomyocytes","volume":"8","author":"Moscato","year":"2018","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.biopha.2024.117278_bib34","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/0008-5472.CAN-21-3652","article-title":"Reengineering ponatinib to minimize cardiovascular toxicity","volume":"82","author":"Hnatiuk","year":"2022","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.117278_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jcm9030820","article-title":"Ponatinib induces vascular toxicity through the notch-1 signaling pathway","volume":"9","author":"Madonna","year":"2020","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.117278_bib36","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/biomedicines10112983","article-title":"Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy","volume":"10","author":"Mihaljevi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.117278_bib37","article-title":"Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice","volume":"18","author":"Takahashi","year":"2019","journal-title":"Biochem Biophys. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.117278_bib38","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1039\/D3FO01379K","article-title":"Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury","volume":"14","author":"Shelke","year":"2023","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.biopha.2024.117278_bib39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbadis.2014.05.005","article-title":"Autophagy and oxidative stress in cardiovascular diseases","volume":"1852","author":"Mei","year":"2015","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2024.117278_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tox.2018.01.005","article-title":"Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells","volume":"395","author":"Paech","year":"2018","journal-title":"Toxicology"},{"issue":"12","key":"10.1016\/j.biopha.2024.117278_bib41","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/01.RES.0000227572.45891.2c","article-title":"Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation","volume":"98","author":"Ek-Vitorin","year":"2006","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117278_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2012.07.004","article-title":"Uremic toxin p-cresol induces disassembly of gap junctions of cardiomyocytes","volume":"302","author":"Peng","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2024.117278_bib43","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.ijcard.2012.07.017","article-title":"Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells","volume":"167","author":"Madonna","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2024.117278_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107091","article-title":"Transcriptional regulation of vascular smooth muscle cell proliferation, differentiation and senescence: novel targets for therapy","volume":"146","author":"Khachigian","year":"2022","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.biopha.2024.117278_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbrc.2019.09.104","article-title":"Regulation of SRF protein stability by an autophagy-dependent pathway","volume":"521","author":"Luo","year":"2020","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.biopha.2024.117278_bib46","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Katsuragi","year":"2015","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.biopha.2024.117278_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11897-021-00519-w","article-title":"The interplay between autophagy and senescence in anthracycline cardiotoxicity","volume":"18","author":"Russo","year":"2021","journal-title":"Curr. Heart Fail Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.117278_bib48","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230258","article-title":"Cx43 can form functional channels at the nuclear envelope and modulate gene expression in cardiac cells","volume":"13","author":"Martins-Marques","year":"2023","journal-title":"Open Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117278_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cellsig.2005.08.012","article-title":"Connexins and their channels in cell growth and cell death","volume":"18","author":"Vinken","year":"2006","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.biopha.2024.117278_bib50","first-page":"93","article-title":"Proteins and mechanisms regulating gap-junction assembly, internalization, and degradation","volume":"28","author":"Th\u00e9venin","year":"2013","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.biopha.2024.117278_bib51","doi-asserted-by":"crossref","first-page":"11762","DOI":"10.1074\/jbc.RA119.009162","article-title":"Cx43 phosphorylation-mediated effects on ERK and Akt protect against ischemia reperfusion injury and alter the stability of the stress-inducible protein NDRG1","volume":"294","author":"Solan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.117278_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102979","article-title":"Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis","volume":"69","author":"Li","year":"2024","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117278_bib53","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1038\/s41467-018-05449-1","article-title":"Phosphorylation of ULK1 affects autophagosome fusion and links chaperone-mediated autophagy to macroautophagy","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2024.117278_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","article-title":"Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2","volume":"147","author":"Chen","year":"2023","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119160","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000}},{"DOI":"10.1016\/j.biopha.2026.119160","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:32:15Z","timestamp":1777861935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224011624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"alternative-id":["S0753332224011624"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117278","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117278"}}